Jet.AI Inc.Non-binding LOI for $320M business combination; outcome uncertain, subject to due diligence and approvals.
Jet.AI announced a non-binding letter of intent for a proposed business combination with a privately held operating company in a transaction valued at approximately $320 million in enterprise value. The proposed deal would merge the existing Jet.AI entity with the unidentified operating company while retaining the NASDAQ ticker JTAI, and simultaneously spin off its data center business into an independent public company under the reserved ticker DCTR. Completion remains subject to due diligence, definitive agreements, shareholder approvals, regulatory clearances, and Nasdaq listing requirements. Separately, Xeriant received U.S. Patent No. 12,679,047 for its multilayered fire-resistant polymer composite technology used in its DUREVER materials platform and NEXBOARD construction panels. Picard Medical reported an 85% year-over-year increase in first-quarter 2026 revenue and improved gross margin to 24%, while continuing development of its Emperor artificial heart platform. Lucid attracted renewed retail investor attention following a rebound from unfounded bankruptcy rumors.
Jet.AI Inc.Non-binding LOI for $320M business combination; outcome uncertain, subject to due diligence and approvals.
Picard Medical, Inc.85% YoY revenue increase and improved gross margin to 24% in Q1 2026.
Lucid Group IncReceived U.S. patent for fire-resistant polymer composite technology.